DYSTROGEN

Dystrogen Therapeutics is a clinical-stage life sciences company committed to developing personalized therapies for rare genetic diseases... Dystrogen Therapeutics is currently focused on the development of a chimeric cell-based therapy platform. The company is testing dystrophin expressing chimeric (DEC) cells, cell-based therapy for the treatment of Duchenne muscular dystrophy.

Also known as: Dystrogen Therapeutics, Dystrogen Therapeutics Corp, Dystrogen Therapeutics Corporation

Primary location: Chicago United States